Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0031514 | motile cilium | 5 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: E9ANC9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 65 | 69 | PF00656 | 0.420 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.369 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.302 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 248 | 250 | PF00675 | 0.300 |
CLV_NRD_NRD_1 | 319 | 321 | PF00675 | 0.329 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.315 |
CLV_NRD_NRD_1 | 372 | 374 | PF00675 | 0.116 |
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.420 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.312 |
CLV_PCSK_FUR_1 | 317 | 321 | PF00082 | 0.334 |
CLV_PCSK_FUR_1 | 350 | 354 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.347 |
CLV_PCSK_KEX2_1 | 248 | 250 | PF00082 | 0.300 |
CLV_PCSK_KEX2_1 | 317 | 319 | PF00082 | 0.326 |
CLV_PCSK_KEX2_1 | 352 | 354 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.312 |
CLV_PCSK_PC7_1 | 314 | 320 | PF00082 | 0.361 |
CLV_PCSK_PC7_1 | 348 | 354 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 193 | 197 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 302 | 306 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.180 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.315 |
DEG_APCC_DBOX_1 | 259 | 267 | PF00400 | 0.315 |
DEG_APCC_DBOX_1 | 317 | 325 | PF00400 | 0.334 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.619 |
DOC_CYCLIN_RxL_1 | 314 | 326 | PF00134 | 0.323 |
DOC_MAPK_gen_1 | 314 | 324 | PF00069 | 0.330 |
DOC_MAPK_gen_1 | 53 | 62 | PF00069 | 0.315 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.670 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 29 | 33 | PF00917 | 0.524 |
DOC_USP7_UBL2_3 | 193 | 197 | PF12436 | 0.300 |
DOC_WW_Pin1_4 | 30 | 35 | PF00397 | 0.523 |
LIG_14-3-3_CanoR_1 | 121 | 125 | PF00244 | 0.385 |
LIG_14-3-3_CterR_2 | 395 | 397 | PF00244 | 0.398 |
LIG_Clathr_ClatBox_1 | 321 | 325 | PF01394 | 0.334 |
LIG_eIF4E_1 | 88 | 94 | PF01652 | 0.385 |
LIG_FHA_2 | 2 | 8 | PF00498 | 0.441 |
LIG_LIR_Nem_3 | 213 | 219 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 386 | 392 | PF02991 | 0.334 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.385 |
LIG_SH2_STAT3 | 88 | 91 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 389 | 392 | PF00017 | 0.334 |
LIG_SUMO_SIM_par_1 | 320 | 326 | PF11976 | 0.334 |
LIG_TRAF2_1 | 254 | 257 | PF00917 | 0.379 |
LIG_TRAF2_1 | 331 | 334 | PF00917 | 0.385 |
LIG_TRAF2_1 | 4 | 7 | PF00917 | 0.563 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.556 |
MOD_CK2_1 | 1 | 7 | PF00069 | 0.445 |
MOD_CK2_1 | 328 | 334 | PF00069 | 0.447 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.670 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.634 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.474 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.425 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.653 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.657 |
MOD_NEK2_1 | 285 | 290 | PF00069 | 0.409 |
MOD_NEK2_1 | 359 | 364 | PF00069 | 0.420 |
MOD_PIKK_1 | 364 | 370 | PF00454 | 0.316 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.155 |
MOD_PKA_2 | 120 | 126 | PF00069 | 0.308 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.420 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.444 |
MOD_Plk_1 | 1 | 7 | PF00069 | 0.445 |
MOD_Plk_1 | 256 | 262 | PF00069 | 0.447 |
MOD_Plk_4 | 277 | 283 | PF00069 | 0.315 |
MOD_ProDKin_1 | 30 | 36 | PF00069 | 0.517 |
MOD_SUMO_for_1 | 254 | 257 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 220 | 226 | PF00179 | 0.447 |
MOD_SUMO_rev_2 | 50 | 57 | PF00179 | 0.334 |
TRG_DiLeu_BaEn_1 | 227 | 232 | PF01217 | 0.420 |
TRG_DiLeu_BaEn_4 | 256 | 262 | PF01217 | 0.420 |
TRG_DiLeu_BaLyEn_6 | 317 | 322 | PF01217 | 0.334 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.315 |
TRG_ER_diArg_1 | 229 | 231 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 316 | 319 | PF00400 | 0.301 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.312 |
TRG_Pf-PMV_PEXEL_1 | 229 | 233 | PF00026 | 0.362 |
TRG_Pf-PMV_PEXEL_1 | 241 | 245 | PF00026 | 0.258 |
TRG_Pf-PMV_PEXEL_1 | 319 | 323 | PF00026 | 0.345 |
TRG_Pf-PMV_PEXEL_1 | 78 | 83 | PF00026 | 0.315 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL07 | Leptomonas seymouri | 80% | 100% |
A0A0S4INL6 | Bodo saltans | 52% | 100% |
A0A1X0NQD2 | Trypanosomatidae | 69% | 100% |
A0A3Q8IC89 | Leishmania donovani | 95% | 100% |
A0A3R7KAZ0 | Trypanosoma rangeli | 68% | 100% |
A4H6A7 | Leishmania braziliensis | 92% | 100% |
A4HUN1 | Leishmania infantum | 95% | 100% |
C9ZVR5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 100% |
Q0VC09 | Bos taurus | 29% | 100% |
Q32LJ7 | Bos taurus | 29% | 100% |
Q4QH95 | Leishmania major | 96% | 100% |
Q4R698 | Macaca fascicularis | 29% | 100% |
Q6AXN9 | Rattus norvegicus | 29% | 100% |
Q6AYL4 | Rattus norvegicus | 29% | 100% |
Q8N443 | Homo sapiens | 29% | 100% |
Q9D0B8 | Mus musculus | 31% | 100% |
Q9D4Q1 | Mus musculus | 29% | 100% |
Q9H4K1 | Homo sapiens | 30% | 100% |
V5BPA3 | Trypanosoma cruzi | 68% | 100% |